Prescription Drug Injuries
Tens of thousands of Americans die each year due to side effects from using prescription drugs. While the FDA is charged with studying prescription drug side effects before allowing them to be placed on the market, there are increasing concerns that the FDA is bowing to pressure from large pharmaceutical companies to allow questionable drugs to remain on the market. At Brennan, Holden & Kavouklis, P.A., we are committed to assisting persons who have been harmed due to the use of prescription drugs. We can assist prescription drug users in having their potential claims investigated to see whether they have a viable claim related to the use of a particular drug. We are handling cases involving the following drugs and medical devices.
BAYCOL - BAYCOL is a cholesterol-lowering medication that was initially approved by the FDA in 1997. BAYCOL was prescribed to reduce cholesterol and to reduce the risk of heart disease. Health problems which have been attributed to BAYCOL usage include death, kidney failure, liver injury and a rare disease called rhabdomyolysis. Rhabdomyolysis can cause severe muscle pain, most frequently in the lower back and calves. It can also lead to fatal kidney failure and other organ damage. Other symptoms of rhabdomyolysis include muscle pain, weakness, tenderness, fever, dark urine, nausea and vomiting. If you have formerly used BAYCOL and you experienced any of these symptoms in proximity to the use of this drug, please call us at 813-279-8076 for assistance with an investigation into your rights to pursue a claim. You can also contact us by email.
MERIDIA - Our law firm is still investigating claims on behalf of the users of this popular diet drug manufactured by Abbott Laboratories. Because of reported cases of heart damage related to the use of this drug, the consumer advocacy group Public Citizen has been lobbying the FDA to withdraw MERIDIA from the market. If you were a MERIDIA user and you would like assistance with an investigation into whether you have a viable claim, please call us at 813-254-7770, or contact us by email.
SERZONE - SERZONE is an antidepressant that has been linked to liver failure. According to the manufacturer, the rate of liver failure associated with SERZONE use is about three to four times greater than that for non-users. Bristol-Myers, the maker of SERZONE, issued a manufacturer's warning on January 9, 2002, telling healthcare providers that "cases of life-threatening hepatic failure have been reported in patients treated with SERZONE." On December 7, 2001, the U.S. Food and Drug Administration told Bristol-Myers that it must include "black box" warnings on all SERZONE labels. The FDA now requires that SERZONE package labels include warnings that "cases of life-threatening hepatic failure have been reported in patients treated with SERZONE." If you have used SERZONE and feel you might have a liver injury or ailment caused by the use of this drug, please contact us for a free case evaluation or call Brennan, Holden & Kavouklis, P.A. at 813-254-7770.
Please be sure to provide us with as much information as is reasonably available. The quality of our evaluation is dependent upon the accuracy of the information you provide to us. Any initial consultation with Brennan, Holden & Kavouklis, P.A. is free. For more information, call us at 813-254-7770 or email us.